Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
IMV Inc
IMVIF
Healthcare
Biotechnology
IMV Inc. is a Canada-based company. The Company has no business operations.
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (GREY:IMVIF)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Nov 25, 2022 4:06pm
New Press Release - IMV Receives Nasdaq Notification Regarding Market Value of Listed Securities
IMV Inc. (“IMV” or the “Company”) (NASDAQ: IMV; TSX: IMV), a clinical-stage company developing a portfolio of immune-educating therapies based on its novel DPX® platform to treat solid and hematologic cancers, today announced that, on November 22, 2022, the Company received a notification letter...
read article.
(4)
•••
zalmonella
X
View Profile
View Bullboard History
Comment by
zalmonella
on Nov 21, 2022 5:03pm
RE:hope the mrkt's wrong
Wouldn't have thought to look for insider buying but certainly almost nobody is triggering their rights purchases either. Now, they've still got money, and as they're not really doing any
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Nov 10, 2022 4:14pm
New Press Release - IMV Inc. Announces Third Quarter 2022 Financial and Operational Results
IMV Inc. (Nasdaq: IMV; TSX: IMV) (“IMV” or the “Company”), a clinical-stage biopharmaceutical company developing a portfolio of immune-educating therapies based on its novel DPX® platform to treat solid and hematologic cancers, today announced its financial and operational results and provided an...
read article.
(2)
•••
antigua1987
X
View Profile
View Bullboard History
Post by
antigua1987
on Nov 09, 2022 1:12pm
hope the mrkt's wrong
1) andy seems to be running out the clock on his contract - 'damage was done before he got to imv' he shrugs. just doing some housekeep before he moves on. 2) RS will be 10/1 as SP falls
...more
(10)
•••
prosciutto
X
View Profile
View Bullboard History
Post by
prosciutto
on Nov 09, 2022 1:05pm
Next draw down
Im concerned about our next draw down and wondering what the current sentiment was. If they attempt to raise 10$+ million as they have done in the past @ .30/share that will be close to a controlling
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Nov 08, 2022 7:06am
New Press Release - IMV Inc. to Announce Third Quarter 2022 Results and Host a Conference Call and Webcast on November 11, 2022
IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical-stage company developing a portfolio of immune-educating therapies based on its novel DPX® platform to treat solid and hematologic cancers, today announced that it will hold a conference call and webcast on Friday, November 11, 2022, at 8:00 a.m. ET to...
read article.
(2)
•••
antigua1987
X
View Profile
View Bullboard History
Post by
antigua1987
on Nov 02, 2022 3:00pm
Euro investor tour + Oct 28 mgmt info cirular
The cowlick kid quietly entertains euro $ for Oct 24 - 27. Then on Oct 28 imv releases details of consolidation meeting tbh dec7. So what exactly is he discussing with POTENTIAL investors for the 4
...more
(2)
•••
europe10
X
View Profile
View Bullboard History
Post by
europe10
on Oct 31, 2022 12:40pm
IMV last breath?
Another consolidation 10:1 or 5:1 And an inevitable financing coming up any day Current shareholder value - what is left of it - to be more or less wiped out
(10)
•••
prosciutto
X
View Profile
View Bullboard History
Comment by
prosciutto
on Oct 21, 2022 12:27pm
RE:RE:RE:we AREN'T done yet people
aha- a bridge maybe, or .... some swamp land in florida. The ratings are max 3 months old, what has changed? Its not over till the fat lady sings
(10)
•••
various
X
View Profile
View Bullboard History
Comment by
various
on Oct 20, 2022 4:46pm
RE:RE:we AREN'T done yet people
Really? You don't think that information is at least a little bit dated and automatically carried over by the site algorithms? You see this getting to $9.40 when it's at .45? I'd like to
...more
(10)
•••
prosciutto
X
View Profile
View Bullboard History
Comment by
prosciutto
on Oct 20, 2022 2:51pm
RE:we AREN'T done yet people
https://www.nasdaq.com/market-activity/stocks/imv/analyst-research
(10)
•••
prosciutto
X
View Profile
View Bullboard History
Post by
prosciutto
on Oct 20, 2022 2:49pm
we AREN'T done yet people
We still have a strong BUY -->
(10)
•••
various
X
View Profile
View Bullboard History
Comment by
various
on Oct 20, 2022 1:58pm
RE:Imv restructuring
This company and "leadership" team are so busy focusing on being politically correct that they haven't done anything meaningful in terms of actual science. Next month they're going
...more
(2)
•••
antigua1987
X
View Profile
View Bullboard History
Post by
antigua1987
on Oct 12, 2022 1:21pm
Special meeting of SH dec 7
3Q fin call s/b 2nd week of Nov. Followed by just-announced spec mtg on dec7. if any posters have seen this situation before (ie, as investor in struggling, early-stage biotech that appears to be on
...more
(2)
•••
europe10
X
View Profile
View Bullboard History
Comment by
europe10
on Oct 11, 2022 3:10pm
RE:RE:Put pressure on the company
Several trials are "open"? Right? So it points towards medicore results? Expect 10:1 reversed split and a huge financing
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Options Trading for Retiring: Key Strategies in Balancing Retirement Income
One Property, One Focus on Advancing this Gold Project in Ontario